United Therapeutics Insider Sold Shares Worth $4,772,295, According to a Recent SEC Filing
MT newswire2026/09/11 20:38Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
04:38 PM EDT, 09/11/2026 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on September 10, 2026, sold 9,500 shares in United Therapeutics (UTHR) for $4,772,295. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 668,728 common shares of the company, with 40,513 shares held directly and 628,215 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1082554/000110657826000139/xslF345X05/primarydocument.xml
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
37 Capital raises $300,000 in private placement at $0.10 per unit
Reuters•2026/09/12 00:04
CrowdStrike CEO George Kurtz disposes of $3.71 million in common shares
Reuters•2026/09/12 00:00
